Neoplasia — INI-CET Previous Year Questions
24 solved PYQs · 2014–2025 · Pathology
- Solved PYQs
- 24
- Years covered
- 2014–2025
- Avg / year
- ~3
- Subject
- Pathology
How many INI-CET questions come from Neoplasia?
Neoplasia has contributed 24 questions to Institute of National Importance Combined Entrance Test papers between 2014 and 2025 — an average of about 3 questions a year. That count is measured from EByAi’s bank of 51,873 INI-CET questions, not estimated from a syllabus. Every one of the 24 questions carries a written, step-by-step solution, and each is tagged to Neoplasia within Pathology, so you can drill this chapter across every year at once instead of hunting through paper PDFs. Practicing a chapter’s full PYQ history is the fastest way to learn the patterns examiners reuse.
Sample Neoplasia questions from real INI-CET papers
These are 5 real questions from the bank — exactly as asked, with the answer one tap away. All 24 Neoplasia questions (with full written solutions) are available in practice.
Question 1 · INI-CET 2025
Which of the following malignancies is unrelated to obesity?- (A)Pancreas
- (B)Stomach
- (C)Meningioma
- (D)Multiple myeloma
Show answerAnswer
Answer: (D) Multiple myelomaQuestion 2 · INI-CET 2025
Which of the following is wrongly matched with its classification?- (A)Boston classification - Colon preparation for colonoscopy
- (B)Mannheim classification - Chronic pancreatitis
- (C)Miami classification - Parathyroid adenoma and hyperplasia differentiation
- (D)LA classification - Achalasia
Show answerAnswer
Answer: (D) LA classification - AchalasiaQuestion 3 · INI-CET 2024
In which type of lung carcinoma is the p53 mutation most commonly observed?- (A)Adenocarcinoma
- (B)Squamous cell carcinoma (SCC)
- (C)Large cell carcinoma
- (D)Small cell carcinoma
Show answerAnswer
Answer: (B) Squamous cell carcinoma (SCC)Question 4 · INI-CET 2024
Which is an intranuclear immunohistochemistry marker for neuroendocrine tumors?- (A)NCAM1/CD56
- (B)Chromogranin
- (C)Synaptophysin
- (D)INSM
Show answerAnswer
Answer: (D) INSMQuestion 5 · INI-CET 2024
ER positivity is used as which of the following in the context of breast carcinoma?- (A)Treatment option
- (B)Prognostic marker
- (C)Molecular marker
- (D)Diagnostic marker
Show answerAnswer
Answer: (B) Prognostic marker
Neoplasia questions by year
| Year | Questions | Share of chapter questions |
|---|---|---|
| 2025 | 4 | |
| 2024 | 3 | |
| 2023 | 7 | |
| 2022 | 4 | |
| 2021 | 2 | |
| 2019 | 1 | |
| 2017 | 1 | |
| 2015 | 1 | |
| 2014 | 1 |
Practice these 24 questions with solutions
Free to start — 25 past-year questions a day with full written solutions, no card needed.
Start Neoplasia practice freeFAQs
How many INI-CET questions have been asked from Neoplasia?
EByAi's bank holds 24 real INI-CET questions from Neoplasia, asked between 2014 and 2025 — about 3 per year on average. Every count is measured from actual papers, not estimated.
Is Neoplasia important for INI-CET?
24 questions over 9 papers make Neoplasia a steady-weightage chapter in INI-CET Pathology. The year-wise table above shows exactly how often it appears.
Can I solve Neoplasia PYQs online for free?
Yes. EByAi lets you solve INI-CET past-year questions in the browser with written solutions — free daily practice, no card needed.